AA

Active Director Director DIN 08543514
DIN 08543514 First appointment Aug 2019 Primary industry Food And Beverages
Unlock full profile Investments · shareholding · contact details
Current companies 1 active board seats
Total affiliations 1 Since Aug 2019
Shareholding value •••• Premium profile

About Atul Atre

Data last updated:

Atul Atre is a Director at Osbone Pharmaceuticals Private Limited (since 2019). The company operates in Food And Beverages. Osbone Pharmaceuticals Private Limited reported revenue of ₹16.8 Lakh (FY 2020).

DIN 08543514
Primary Designation Director
Industry Food And Beverages
First Appointment 29 Aug 2019
Oldest Company Age 10 yrs
Largest company Osbone Pharmaceuticals Private Limited · ₹16.8 Lakh (FY 2020)

Current companies

CompanyDesignationAppointmentFoundedRevenueStatus
Director29 Aug 20192016₹16.8 Lakh (FY 2020)Active

Board colleagues of Atul Atre

NameDINCompanyDesignation
Sawan Sharma07621455Osbone Pharmaceuticals Private LimitedDirector

Directorship timeline

Open interactive timeline →
Osbone Pharmaceuticals Private Limited
Premium access

Shareholding and investment profile for Atul Atre

Company-level share counts, filed values, and quarterly changes require authenticated premium access.

  • Company-level holdings
  • Filed share counts
  • Reported values
  • Quarterly changes
Unlock shareholding

Verified entity values are shown only after access is granted.

Frequently Asked Questions about Atul Atre

Atul Atre currently holds 1 directorship: Osbone Pharmaceuticals Private Limited (Director, since 29 Aug 2019, revenue ₹16.8 Lakh (FY 2020)).

Atul Atre was first appointed on 29 Aug 2019 as Director at Osbone Pharmaceuticals Private Limited.

The current boards of Atul Atre's companies include Sawan Sharma (Osbone Pharmaceuticals Private Limited).

Explore millions of companies — effortlessly

Access structured, verified intelligence on 7M+ companies across industries, sectors, and global markets. From early-stage startups to large enterprises, discover ownership, leadership, funding, financials, acquisitions, and market signals — all in one powerful platform.

Free account with essential features Instant access to company reports Enterprise solutions available